Holen Sie sich die Stockscreener-App
67.72
0.31%
-0.21
Vorhandelsmarkt:
72.01
4.29
+6.33%
Ptc Therapeutics Inc Aktie (PTCT) Neueste Nachrichten
Transcript : PTC Therapeutics, Inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
PTC Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat
PTC Therapeutics Inc (PTCT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
PTC Therapeutics Reports Strong Q3 2025 Results - TipRanks
PTC Therapeutics : Corporate Presentation – November 2025 - MarketScreener
Compared to Estimates, PTC Therapeutics (PTCT) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: PTC Therapeutics Q3 2025 sees surprise EPS beat - Investing.com
PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
PTC Therapeutics Swings To Profit On Strong New Drug Uptake - Finimize
PTC Therapeutics : Q3 2025 FLS - MarketScreener
PTC Therapeutics Q3 2025 Earnings: Revenue Surges to $211 Millio - GuruFocus
PTC Therapeutics Reports Strong Q3 2025 Financial Results - TipRanks
PTC Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle
[10-Q] PTC THERAPEUTICS, INC. Quarterly Earnings Report | PTCT SEC FilingForm 10-Q - Stock Titan
Earnings Flash (PTCT) PTC Therapeutics, Inc. Reports Q3 Revenue $211.0M, vs. FactSet Est of $172.9M - MarketScreener
Rare‑diseases biopharma firm PTC Therapeutics' Q3 revenue rises to $211 mln - TradingView
[8-K] PTC THERAPEUTICS, INC. Reports Material Event | PTCT SEC FilingForm 8-K - Stock Titan
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - MarketScreener
BRIEF-PTC Therapeutics Q3 Net Income USD 15.896 Million - TradingView
Press Release: PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - 富途牛牛
Wells Fargo Lowers Price Target for PTCT to $73 | PTCT Stock New - GuruFocus
How PTC Therapeutics Inc. stock compares to growth peersEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Hussman Strategic Advisors Inc. Increases Stock Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
Will PTC Therapeutics Inc. (BH3) stock deliver stable dividendsEarnings Growth Summary & Technical Buy Zone Confirmations - newser.com
How PTC Therapeutics Inc. stock benefits from global expansionJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Why PTC Therapeutics Inc. (BH3) stock is trending on social mediaCEO Change & Verified Technical Signals - newser.com
Published on: 2025-11-04 01:32:27 - newser.com
Is PTC Therapeutics Inc. (BH3) stock safe for risk averse investorsTreasury Yields & Real-Time Stock Entry Alerts - newser.com
Sector ETF performance correlation with PTC Therapeutics Inc.Treasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
What To Expect From PTC Therapeutics Inc (PTCT) Q3 2025 Earnings - GuruFocus
Will PTC Therapeutics Inc. (BH3) stock attract long term capital inflowsShort Setup & Free Technical Pattern Based Buy Signals - newser.com
Detecting support and resistance levels for PTC Therapeutics Inc.2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
How to forecast PTC Therapeutics Inc. trends using time seriesMarket Growth Report & Breakout Confirmation Trade Signals - newser.com
How to read the order book for PTC Therapeutics Inc.Weekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com
Wolverine Asset Management LLC Trims Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. $PTCT Stake Lessened by Pinnacle Associates Ltd. - MarketBeat
PTC Therapeutics, Inc. $PTCT Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Can PTC Therapeutics Inc. stock reach $100 price targetWeekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
PTC Therapeutics, Inc. (PTCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is PTC Therapeutics Inc. stock a top pick in earnings season2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Brighton Jones LLC Invests $226,000 in PTC Therapeutics, Inc. $PTCT - MarketBeat
Published on: 2025-11-02 01:56:33 - newser.com
PTC Therapeutics submits NDA for Friedreich ataxia treatment vatiquinone - MSN
PTC Therapeutics (NASDAQ:PTCT) Director Sells $1,088,787.00 in Stock - MarketBeat
PTC Therapeutics Hits New 52-Week High of $69.88, Up 81.1% - Markets Mojo
AlphaQuest LLC Raises Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
Published on: 2025-11-01 00:56:06 - newser.com
Insider Sell: Emma Reeve Sells 15,666 Shares of PTC Therapeutics Inc (PTCT) - GuruFocus
PTC Therapeutics Inc expected to post a loss of $1.37 a shareEarnings Preview - TradingView
Reeve Emma, director at Ptc Therapeutics, sells $1.08 million in shares - Investing.com Australia
Reeve Emma, director at Ptc Therapeutics, sells $1.08 million in shares By Investing.com - Investing.com South Africa
PTC Therapeutics Director Emma Reeve Sells Shares - TradingView
PTCT insider executes 10b5-1 trades: option exercise and share sales - Stock Titan
PTC Therapeutics (NASDAQ:PTCT) Hits New 12-Month HighWhat's Next? - MarketBeat
Ptc Therapeutics stock hits 52-week high at 69.53 USD By Investing.com - Investing.com Australia
How Investors May Respond To PTC Therapeutics (PTCT) Analysts' Optimism on Sephience Launch Momentum - Sahm
2025-10-31 | PTC Therapeutics to Participate at Upcoming Investor Conferences | NDAQ:PTCT | Press Release - Stockhouse
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):